Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.32 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.32 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.32 |
| ▸ | NAAA | Q02083 | 1/20 | 0.31 |
| ▸ | RAD52 | P43351 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2481162 | 1.00 | TSHR (0.59) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL2480778 | 1.00 | TSHR (0.59) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL1527497 | 1.00 | TSHR (0.59) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL17780845 | 1.00 | TSHR (0.59) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL181712 | 1.00 | TSHR (0.59) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL1850039 | 1.00 | TSHR (0.59) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL5362558 | 1.00 | TSHR (0.59) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL2483259 | 1.00 | TSHR (0.59) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL633702 | 0.98 | TSHR (0.56) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL181751 | 0.93 | TSHR (0.53) | TSHRPOLBAPEX1HTTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 194 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2558441-B1 | PROCESS FOR PRODUCING ISOCYANATES | 3M INNOVATIVE PROPERTIES CO (US) | 2018-05-30 | — | — | EP | claimed |
| US-9006480-B2 | Process for producing isocyanates | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-04-14 | — | — | US | claimed |
| EP-2558441-A1 | PROCESS FOR PRODUCING ISOCYANATES | 3M Innovative Properties Company (US) | 2013-02-20 | — | — | EP | claimed |
| US-20130023694-A1 | PROCESS FOR PRODUCING ISOCYANATES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-01-24 | — | — | US | claimed |
| US-20120205234-A1 | POLYMERIZABLE MONOMER COMPOSITION AND METHOD FOR PREVENTING POLYMERIZATION | SHOWA DENKO K.K. (JP) | 2012-08-16 | — | — | US | claimed |
| WO-2011130032-A1 | PROCESS FOR PRODUCING ISOCYANATES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-10-20 | — | — | WO | claimed |
| EP-2377847-A1 | Process for producing isocyanates | 3M Innovative Properties Company (US) | 2011-10-19 | — | — | EP | claimed |
| US-20100099827-A1 | POLYMERIZABLE MONOMER COMPOSITION AND METHOD FOR PREVENTING POLYMERIZATION | SHOWA DENKO K.K. (JP) | 2010-04-22 | — | — | US | claimed |
| EP-2091994-A1 | POLYMERIZABLE MONOMER COMPOSITION AND METHOD FOR PREVENTING POLYMERIZATION | Showa Denko K.K. (JP) | 2009-08-26 | — | — | EP | claimed |
| WO-2008069256-A1 | POLYMERIZABLE MONOMER COMPOSITION AND METHOD FOR PREVENTING POLYMERIZATION | SHOWA DENKO K.K. (JP) | 2008-06-12 | — | — | WO | claimed |
| US-5213934-A | Core of colorant and binder grafted to polymeric shell | XEROX CORPORATION (US) | 1993-05-25 | — | — | US | claimed |
| CN-122055350-A | Method for producing monomer precursor composition | 东丽株式会社 | 2026-05-15 | — | — | CN | disclosed |
| WO-2025084057-A1 | METHOD FOR PRODUCING MONOMER PRECURSOR COMPOSITION | 東レ株式会社 | 2025-04-24 | — | — | WO | disclosed |
| US-12180136-B2 | Organic amine collection method | ASAHI KASEL KABUSHIKI KAISHA (JP) | 2024-12-31 | — | — | US | disclosed |
| US-20240425448-A1 | METHOD FOR PRODUCING ISOCYANATE COMPOUND, METHOD FOR PRODUCING CARBAMATE COMPOUND, METHOD FOR RECOVERING AMINE COMPOUND, AND ISOCYANATE COMPOSITION | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2024-12-26 | — | — | US | disclosed |
| US-4436885-A | Preparation of isocyanate-functional polymers containing a terminal monosulfide group | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-03-13 | — | — | US | disclosed |
| US-4351755-A | MOISTURE CURABLE COATINGS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-09-28 | — | — | US | disclosed |
| US-4273690-A | Coating compositions of an alkyd-acrylic graft copolymer | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-06-16 | — | — | US | disclosed |
| US-4222909-A | Coating compositions comprising isocyanate-functional polymers containing a terminal thioalkyl group | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1980-09-16 | — | — | US | disclosed |
| US-RE29772-E | IMPACT STRENGTH, CLARITY, WEATHER RESISTANCE | ROHM AND HAAS COMPANY (US) | 1978-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12180136-B2 | Organic amine collection method | H1-0, F12, C1S | TSHR 1695/4885POLB 95/4885APEX1 920/4885 |
| US-20130023694-A1 | PROCESS FOR PRODUCING ISOCYANATES | IDH2, IDH1, IDH3A | TSHR 4866/4885POLB 2495/4885APEX1 1216/4885 |
| US-20240425448-A1 | METHOD FOR PRODUCING ISOCYANATE COMPOUND, METHOD FOR PRODUCING CARBAMATE COMPOUND, METHOD FOR RECOVERING AMINE COMPOUND, AND ISOCYANATE COMPOSITION | IDH3A, CA7, C9 | TSHR 4594/4885POLB 1301/4885APEX1 730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.